Your browser doesn't support javascript.
loading
Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer.
Ihrig, Andreas; Pernt, Pascal Marino; Zschäbitz, Stefanie; Huber, Johannes; Friederich, Hans-Christoph; Bugaj, Till J; Maatouk, Imad.
Afiliación
  • Ihrig A; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany. andreas.ihrig@med.uni-heidelberg.de.
  • Pernt PM; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Zschäbitz S; Department of Medical Oncology, National Centre for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Huber J; Department of Urology, Philipps-University Marburg, Marburg, Germany.
  • Friederich HC; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Bugaj TJ; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Maatouk I; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
Int Urol Nephrol ; 55(11): 2733-2739, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37466904
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Urol Nephrol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Urol Nephrol Año: 2023 Tipo del documento: Article País de afiliación: Alemania